Back to top

Image: Shutterstock

Zoetis (ZTS) in Focus: Stock Moves 6.9% Higher

Read MoreHide Full Article

Zoetis Inc. (ZTS - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $158.55 to $168.34 in the past one-month time frame.

The company has seen two positive estimate revisions in the past month, while the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Zoetis currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Another stock worth considering in the Medical sector is Emergent BioSolutions Inc. (EBS - Free Report) which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Emergent Biosolutions Inc. (EBS) - free report >>

Zoetis Inc. (ZTS) - free report >>

Published in